日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome

一项针对骨髓增生异常综合征患者的1期研究,评估度伐利尤单抗单药治疗或联合曲美利木单抗(加或不加阿扎胞苷)的疗效。

Garcia-Manero, Guillermo; Gaddh, Manila; Platzbecker, Uwe; Lindsley, R Coleman; Larson, Sarah M; Chevassut, Timothy; Fenaux, Pierre; Komrokji, Rami; Lyons, Roger; Al-Kali, Aref; Jiang, Yu; Bothos, John; Townsley, Danielle M; Zeidan, Amer M

ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study

ASCT2靶向抗体药物偶联物MEDI7247治疗复发/难治性血液系统恶性肿瘤成人患者:一项首次人体I期研究

Maris, Michael; Salles, Gilles; Kim, Won Seog; Kim, Tae Min; Lyons, Roger M; Arellano, Martha; Karmali, Reem; Schiller, Gary; Cull, Elizabeth; Abboud, Camille N; Batlevi, Connie; Kagiampakis, Ioannis; Rebelatto, Marlon C; Lee, Young; Kirby, Lyndon C; Wang, Fujun; Bothos, John; Townsley, Danielle M; Fathi, Amir T; Ribrag, Vincent

Interactive Analysis, Exploration, and Visualization of RNA-Seq Data with SeqCVIBE

利用 SeqCVIBE 对 RNA-Seq 数据进行交互式分析、探索和可视化

Bothos, Efthimios; Hatzis, Pantelis; Moulos, Panagiotis

Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS)

临床药物基因组学实践:设计、评估和实施支持中枢神经系统疾病药物选择的新型药物遗传学检测组合

Bothos, E; Ntoumou, E; Kelaidoni, K; Roukas, D; Drakoulis, N; Papasavva, M; Karakostis, F A; Moulos, P; Karakostis, K